Essentially, in a series of normal breast tissue samples (n = 5) and breast cancer cases (n = 43), the authors demonstrated that TRPM4 mRNA expression was significantly higher in breast cancers or patients with higher breast cancer stage, comparable with the observations in our study. This evidence concerns the gene TRPM4 and breast cancer.